Overview

Study of 3 Doses of ARD-0403 in Testosterone Deficient Men

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which dose, if any, results in testosterone levels within the normal range for men.
Phase:
Phase 2
Details
Lead Sponsor:
Ardana Bioscience Ltd
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate